The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD
Thyroid function studies in praderwilli syndrome
And as it does, a picture is emerging that looks very familiar to practitioners of functional and integrative medicineone defined by viral persistence, mitochondrial dysfunction, chronic inflammation, immune dysregulation, microbiome disruption, and autonomic nervous system damage
Your cells use NAD to turn food into energy
Many runners find this the hardest phase psychologically, but patience here pays dividends later
Measurements were performed using a Hologic Discovery Wi DXA scanner and analyzed using APEX software version 13.4